Skip to content

Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain

Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07424638
Enrollment
75
Registered
2026-02-20
Start date
2026-02-21
Completion date
2026-07-30
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Suprascapular Block, Interscalene Block, Shoulder Pain, Thoracotomy

Brief summary

This study aims to compare the frequency of occurrence of ipsilateral shoulder pain in patients undergoing thoracotomy with ultrasound-guided interscalene block, anterior suprascapular block as adjunct to epidural and epidural block only.

Detailed description

Thoracotomy is one type of surgery associated with challenging pain that needs to be promptly addressed to avoid post-operative respiratory complications and aid in effective postoperative physiotherapy and patient recovery. Epidural analgesia is considered the gold standard for the thoracotomy procedure. Ipsilateral shoulder pain (ISP) following thoracotomy has an incidence ranging from 37% to 85%. Being so common, this pain needs more attention and proper anticipation, and management. ISP is usually non-responsive to the effects of epidural and paravertebral blocks.

Interventions

OTHERInterscalene block

Patients will receive an ultrasound-guided interscalene block.

Patients will receive an ultrasound-guided anterior suprascapular block.

OTHEREpidural analgesia

Patients will not receive regional blocks apart from epidural analgesia.

Sponsors

National Cancer Institute, Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years and ≤ 65 years old. * American Society of Anesthesiologists (ASA) physical status II-III. * Body mass index 18-35 kg/m2. * Patients who have a confirmed diagnosis of lung cancer and are scheduled for elective open-lung surgery.

Exclusion criteria

* Allergy to local anesthetics. * Known psychiatric or neurologic disorders. * Alcohol or narcotics abuse. * Contraindications to thoracic epidural or suprascapular block, or interscalene block, e.g., coagulopathy or local infection. * Pre-existing shoulder symptoms. * History of previous thoracotomy. * Severe restrictive or obstructive pulmonary disease. * Pre-existing contralateral diaphragmatic paralysis.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of occurrence of ipsilateral shoulder pain72 hours postoperativelyFrequency of occurrence of ipsilateral shoulder pain will be recorded.

Secondary

MeasureTime frameDescription
Forced Expiratory Volume in 1 second (FEV1)72 hours postoperativelyForced Expiratory Volume in 1 second (FEV1) will be recorded preoperative and at day 0, 1, 2 \& 3 when visual analog scale (VAS) is ≤ 3.
Incidence of complications72 hours postoperativelyIncidence of postoperative complications will be recorded.
Time to first request of rescue analgesia72 hours postoperativelyRescue analgesia with 5 ml of 0.25% bupivacaine through the epidural catheter (in case of thoracotomy pain). Ketorolac 30 mg I.V. over 50 cc saline for breakthrough shoulder pain (will not exceed 120 mg/day).
Total number of rescue analgesia72 hours postoperativelyTotal number of rescue analgesia will be recorded.
Degree of pain72 hours postoperativelyEach patient will be instructed about postoperative pain assessment with the visual analog scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be recorded after intensive care unit (ICU) admission then every 6 h postoperative for 72 h.
Mean arterial pressure48 hours postoperativelyMean arterial pressure will be recorded every 30 minutes and immediately postoperative then every 4 h postoperative for 48 h.
Heart rate48 hours postoperativelyHeart rate will be recorded every 30 minutes and immediately postoperative then every 4 h postoperative for 48 h.
Forced vital capacity (FVC)72 hours postoperativelyForced vital capacity (FVC) will be recorded preoperative and at day 0, 1, 2 \& 3 when visual analog scale (VAS) is ≤ 3.
Peak Expiratory Flow Rate72 hours postoperativelyPeak Expiratory Flow Rate (PEFR) will be recorded as baseline in holding area before premedication and every 6 h postoperative for 72 h when visual analog scale (VAS) is ≤ 3.
Forced Expiratory Volume in 1 second (FEV1) / Forced vital capacity (FVC) ratio72 hours postoperativelyForced Expiratory Volume in 1 second (FEV1) / Forced vital capacity (FVC) ratio will be recorded preoperative and at day 0, 1, 2 \& 3 when visual analog scale (VAS) is ≤ 3.

Countries

Egypt

Contacts

CONTACTMai M Elrawas, MD
mai.elrawas@nci.cu.edu.eg00201222177242

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026